Royalty Pharma plcRPRXNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+80.2%
5Y CAGR+13.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+80.2%/yr
Annual compound
5Y CAGR
+13.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 142.31% |
| 2024 | -5.24% |
| 2023 | 9.87% |
| 2022 | 24.33% |
| 2021 | 0.61% |
| 2020 | 75.67% |
| 2019 | 67.09% |
| 2018 | -41.84% |
| 2017 | 53.12% |
| 2016 | -42.75% |